Plain-English translation of NCT07534033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a probiotic called Lactobacillus rhamnosus LR607 to see if it can enhance the effectiveness of chemotherapy and immunotherapy for people with non-small cell lung cancer. Researchers believe that this medication may work by changing the helpful bacteria in your gut, which could strengthen how your body responds to cancer treatment. The study will also monitor whether the treatment is safe and what side effects, if any, occur.
Standard chemotherapy and immunotherapy help many lung cancer patients, but doctors are always looking for ways to make these treatments work better. This trial is exploring whether this medication could boost your immune system's ability to fight cancer by improving your gut health.
You likely qualify if…
You likely don't qualify if…
You would take the probiotic medication by mouth every day for 3 months while receiving your standard chemotherapy and immunotherapy treatment. During this time, you'll visit the hospital once a month for check-ups and tests to see how you're responding to treatment. Researchers will track how well the cancer responds, whether it comes back, and what side effects you experience.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China